Development and Validation of a RP-HPLC method for Analysis of Cidofovir in Medicinal Form

J  Mamatha  and N  Devanna

doi:10.17485/ijst/2017/v10i34/117108

Article

Development and Validation of a RP-HPLC method for Analysis of Cidofovir in Medicinal Form

VIEWS 1164
PDF 357

Abstract
Full-Text HTML
Full-Text PDF
How to Cite

Indian Journal of Science and Technology

DOI: 10.17485/ijst/2017/v10i34/117108

Year: 2017, Volume: 10, Issue: 34, Pages: 1-5

Original Article

Development and Validation of a RP-HPLC method for Analysis of Cidofovir in Medicinal Form

J. Mamatha¹ and N. Devanna²

¹Department of Chemistry, G. Pullaiah College of Engineering and Technology, Kurnool – 518002, Andhra Pradesh, India; [email protected]²Department of Chemistry, JNTUA College of Engineering, Anantapur – 515002, Andhra Pradesh, India; [email protected]

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Objective: A novel RP-HPLC method has been developed for analysis of cidofovir in its available medicinal form. Method: Stationary phase was a sophisticated C-18 RP Column (250mm × 4.6mm). Mobile phase consisted of Ethylnitrile and 0.005M citric acid buffer (pH adjusted to 5.5) in 60:40 V/V ratio. Mobile phase flow rate was 1.0 ml per minute and Isocratic. UV detection wavelength was 260nm. Validation was carried according to ICH guidelines. Findings: The Retention time of both AP1 and the medicine was 3.88 minutes. Linearity was satisfied over the concentration range of 2 ppm to 10 ppm and r² value was 0.999. LOD and LOQ values were 0.067 ppm and 0.205 ppm respectively. Improvement: The Reported method was novel and all validation parameters met the criteria. Method can be used in quality control analysis.

Keywords: Method Development, Validation, RP - HPLC